CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 54 filers reported holding CYCLERION THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $716,602 | -33.9% | 1,651,536 | 0.0% | 0.00% | – |
| Q4 2022 | $1,083,738 | -23.6% | 1,651,536 | +0.1% | 0.00% | – |
| Q3 2022 | $1,419,000 | +47.4% | 1,650,704 | -5.9% | 0.00% | – |
| Q2 2022 | $963,000 | -50.5% | 1,754,153 | 0.0% | 0.00% | – |
| Q1 2022 | $1,947,000 | -39.5% | 1,754,153 | -6.2% | 0.00% | – |
| Q4 2021 | $3,216,000 | -26.8% | 1,870,363 | +30.6% | 0.00% | – |
| Q3 2021 | $4,396,000 | -20.8% | 1,432,029 | +0.6% | 0.00% | – |
| Q2 2021 | $5,552,000 | +19.2% | 1,423,532 | -14.7% | 0.00% | – |
| Q1 2021 | $4,657,000 | -8.6% | 1,669,139 | +0.2% | 0.00% | – |
| Q4 2020 | $5,095,000 | -51.3% | 1,665,180 | -3.2% | 0.00% | – |
| Q3 2020 | $10,454,000 | +57.7% | 1,719,420 | +53.3% | 0.00% | – |
| Q2 2020 | $6,629,000 | +93.5% | 1,121,604 | -13.2% | 0.00% | – |
| Q1 2020 | $3,425,000 | -2.5% | 1,292,807 | +0.1% | 0.00% | – |
| Q4 2019 | $3,513,000 | -77.6% | 1,291,625 | -0.3% | 0.00% | -100.0% |
| Q3 2019 | $15,699,000 | +22.4% | 1,295,205 | +15.6% | 0.00% | – |
| Q2 2019 | $12,828,000 | – | 1,120,334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MFN Partners Management, LP | 1,487,874 | $17,036,000 | 2.70% |
| BRIDGER MANAGEMENT, LLC | 1,032,633 | $11,824,000 | 0.93% |
| EcoR1 Capital, LLC | 776,206 | $8,888,000 | 0.90% |
| Camber Capital Management LP | 1,561,915 | $17,884,000 | 0.83% |
| CVI Holdings, LLC | 157,114 | $1,798,000 | 0.70% |
| Artal Group S.A. | 1,361,584 | $15,590,000 | 0.63% |
| Slate Path Capital LP | 714,018 | $8,176,000 | 0.37% |
| Sarissa Capital Management LP | 250,000 | $2,862,000 | 0.36% |
| AWH Capital, L.P. | 10,107 | $116,000 | 0.17% |
| Broderick Brian C | 32,919 | $377,000 | 0.13% |